HFU 22 Header

Saturday, May 14

Overall Congress Learning Objectives:

Following the program, participants will be able to: 

  1. Describe the latest approaches to diagnosis and treatment of Heart Failure due to Preserved EF (communicator, leader)

  2. Understand clinical scenarios for consideration of special cardiomyopathies (scholar, medical expert) 

  3. Use practical and efficient approaches to treatment of HF due to Reduced EF (collaborator, professional) 

  4. Describe novel drugs and devices for treatment of heart failure (communicator, health advocate)

Please note that all times are set to Eastern Time (ET) (UTC-4)

8:00 a.m.
Breakfast Buffet Opens
8:30 - 9:30 a.m. ET
BREAKFAST SYMPOSIUM (unaccredited)

PLENARY SESSION 3:

Canadian Heart Failure Society (CHFS) & Heart Failure
Association of the ESC (HFA)
Joint Plenary Session
PREVENTING RECURRENT HOSPITALIZATIONS
CO-CHAIRS:
Shelley Zieroth, MD (CHFS)
Andrew Coats, MD (President, HFA)
9:40 a.m.
Plenary Opening Remarks
Shelley Zieroth, MD
9:55 a.m.
Worsening HF: What is it and Why is it Important?
Ovidiu Chioncel, MD
10:10 a.m.
Diuretics and 'New' Drugs in AHF
Peter Liu, MD
10:25 a.m.
Managing AF in Acute HF
Katia Dyrda, MD
10:40 a.m.
Identifying the 'Sweet Spot' for Invasive Hemodynamic Monitoring
Finn Gustafsson, MD
10:55 a.m.
Plenary Q&A

SÉANCE PLÉNIÈRE 3:

PRÉVENIR LES HOSPITALISATIONS RÉCURRENTES
CO-PRÉSIDENTS:
Kim Anderson, MD
Serge Lepage, MD
9:40 a.m.
Mots de bienvenue
Serge Lepage, MD
9:55 a.m.
Détérioration clinique de l’insuffisance cardiaque : pathophysiologie et importance clinique
Mathieu Bernier, MD
10:10 a.m.
Approche à l’insuffisance cardiaque aiguë : Diurétique et nouvelles avenues de traitement
Normand Racine, MD
10:25 a.m.
Prise en charge de la FA en ADHF
Jean-François Roux, MD
10:40 a.m.
Utilisation judicieuse du monitoring invasif
Catherine Bourque, MD
10:55 a.m.
Questions-réponses en plénière
11:15 a.m.
BREAK (for in person delegates)
11:20 - 11:40 a.m.
CORRIDOR CONSULTS (for online delegates) Unaccredited – Choose to Attend one of our Engaging Faculty-Lead Sessions

WORKSHOPS

Choose one to Attend
11:45 a.m. - 12:30 p.m.
1. Special Cardiomyopathies: Focus on Treatment
Margot Davis, MD
Michael McDonald, MD
Robert McKelvie, MD
11:45 a.m. - 12:30 p.m.
2. Treatment of Refractory HF
Jennifer Amadio, MD
Stephanie Poon, MD
11:45 a.m. - 12:30 p.m.
3. Managing Depression in Heart Failure
Heather Tulloch, MD
Karen Harkness, RN, PhD
11:45 a.m. - 12:30 p.m.
4. Practically Starting and Stopping GDMT
Jacinthe Boulet, MD
Emmanuelle Ménard-Massie, MD
12:30 p.m.
Lunch Buffet Opens
12:50 - 1:50 p.m.
LUNCH SYMPOSIUM (unaccredited)

PLENARY 4:

Canadian Heart Failure Society (CHFS) & Heart Failure Society of America (HFSA)
Joint Plenary Session
CUTTING EDGE HF THERAPIES
CO-CHAIRS
Anique Ducharme, MD (President, CHFS)
Mark Drazner, MD (President, HFSA)
2:00 p.m.
Presentation of Awards: CHFN & Trainee Research Competition
Jonathan Howlett, MD
Anique Ducharme, MD
2:10 p.m.
Plenary Opening Remarks
Anique Ducharme, MD
2:15 p.m.
Has COVID-19 Taught us Anything about HF?
Anuradha Lala-Trinidade, MD
2:30 p.m.
New Devices for HF
Akshay S. Desai, MD
2:45 p.m.
Successes and Challenges with Percutaneous Valve Therapy
Anita Asgar, MD
3:00 p.m.
Challenges with ''Destination Therapy" in Canada
Nakul Sharma, MD
3:15 p.m.
Plenary Q&A
3:35 p.m.
Congress Closing Remarks
Shelley Zieroth, MD
3:45 - 4:05 p.m.
Day 2 Highlights From our Co-Chairs
Jonathan Howlett, MD
Serge Lepage, MD
Shelley Zieroth, MD

 

Follow @CanHFSociety Along on Twitter

#HFUpdate